Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 871

The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.

Insulin Degradation: Progress and Potential*

Open access
Duckworth, William C., Bennett, Robert G., Hamel, Frederick G. · 1998 · Endocrine Reviews

Abstract

Insulin degradation is a regulated process that plays a role in controlling insulin action by removing and inactivating the hormone. Abnormalities in insulin clearance and degradation are present in various pathological conditions including type 2 diabetes and obesity and may be important in producing clinical problems. The uptake, processing, and degradation of insulin by cells is a complex process with multiple intracellular pathways. Most evidence supports IDE as the primary degradative mechanism, but other systems (PDI, lysosomes, and other enzymes) undoubtedly contribute to insulin metabolism. Recent studies support a multifunctional role for IDE, as an intracellular binding, regulatory, and degradative protein. IDE increases proteasome and steroid hormone receptor activity, and this activation is reversed by insulin. This raises the possibility of a direct intracellular interaction of insulin with IDE that could modulate protein and fat metabolism. The recent findings would place intracellular insulin-IDE interaction into the insulin signal transduction pathway for mediating the intermediate effects of insulin on fat and protein turnover.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/edrv.19.5.0349

Cites

141 of 141 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 97

  1. Duckworth, 1997, The significance of intracellular insulin to insulin action., J Invest Med, 45, 20
  2. Sonne, 1986, The reversible receptor binding of insulin in isolated rat adipocytes measured at 37 degrees: the binding is not rate limiting for cellular uptake., Biochim Biophys Acta, 886, 302, 10.1016/0167-4889(86)90149-7 · doi:10.1016/0167-4889(86)90149-7
  3. Sato, 1991, Receptor-recycling model of clearance and distribution of insulin in the perfused mouse liver., Diabetologia, 34, 613, 10.1007/BF00400989 · doi:10.1007/bf00400989
  4. Jochen, 1989, Kinetics of insulin internalization and processing in adipocytes: effects of insulin concentration., J Cell Physiol, 141, 527, 10.1002/jcp.1041410311 · doi:10.1002/jcp.1041410311
  5. Benzi, 1994, Insulin degradation in vitro and in vivo: a comparative study in men. Evidence that immunoprecipitable, partially rebindable degradation products are released from cells and circulate in blood., Diabetes, 43, 297, 10.2337/diab.43.2.297 · doi:10.2337/diab.43.2.297
  6. Caro, 1981, Evidence for modulation of insulin action and degradation independently of insulin binding, Am J Physiol, 240, E325
  7. Adrogue, 1996, Glyburide increases the secretion, tissue uptake, and action of insulin in conscious normal dogs., Metabolism, 45, 579, 10.1016/S0026-0495(96)90027-X · doi:10.1016/s0026-0495(96)90027-x
  8. Auletta, 1994, Insulin-degrading activity in experimental liver cirrhosis of the rat., Enzyme Protein, 95, 197, 10.1159/000474989 · doi:10.1159/000474989
  9. Antoniello, 1989, Insulin and glucagon degradation in liver are not affected by hepatic cirrhosis., Clin Chim Acta, 183, 343, 10.1016/0009-8981(89)90369-0 · doi:10.1016/0009-8981(89)90369-0
  10. Hysing, 1989, Renal Uptake and degradation of trapped-label insulin., Renal Physiol Biochem, 12, 228
  11. Nielsen, 1992, Time course and kinetics of proximal tubular processing of insulin, Am J Physiol, 262, F813
  12. Fawcett, 1995, Sequential processing of insulin by cultured kidney cells., Endocrinology, 136, 39, 10.1210/endo.136.1.7828556 · doi:10.1210/endo.136.1.7828556
  13. Surmacz, 1988, Uptake and intracellular fate of [14C] sucrose-insulin in perfused rat livers, Am J Physiol, 255, C70, 10.1152/ajpcell.1988.255.1.C70 · doi:10.1152/ajpcell.1988.255.1.c70
  14. Dahl, 1990, Effect of bacitracin on the retroendocytosis and degradation of insulin in cultured kidney epithelial cell line., Diabetes, 39, 1339, 10.2337/diab.39.11.1339 · doi:10.2337/diab.39.11.1339
  15. Vries, 1990, Effect of the insulin degradation inhibitors bacitracin and chloroquine on insulin binding data to H35 rat hepatoma cells., Diabete Metab, 16, 70
  16. Medina, 1993, Purification of nonantibiotic insulinase inhibitors from bacitracin., Biochem Med Metab Biol, 49, 255, 10.1006/bmmb.1993.1027 · doi:10.1006/bmmb.1993.1027
  17. Heckmeyer, 1982, Selective antilipolytic effect of bacitracin in the isolated fat cell., Biochem Biophys Res Commun, 108, 336, 10.1016/0006-291X(82)91871-X · doi:10.1016/0006-291x(82)91871-x
  18. Rabkin, 1979, Effect of prolonged uremia on insulin metabolism by isolated liver and muscle., Kidney Int, 16, 433, 10.1038/ki.1979.148 · doi:10.1038/ki.1979.148
  19. Jochen, 1987, Effects of metalloendoprotease inhibitors on insulin binding, internalization and processing in adipocytes., Biochem Biophys Res Commun, 142, 205, 10.1016/0006-291X(87)90472-4 · doi:10.1016/0006-291x(87)90472-4
  20. Ardevol, 1996, Adipose tissue extraction of circulating insulin in anaesthetized Zucker obese rats., Int J Obes, 20, 837
  21. Baldwin Jr, 1981, Insulin binding, internalization, and receptor regulation in cultured human fibroblasts, Am J Physiol, 241, E251
  22. Powers, 1980, Insulin degradation by mononuclear cells., Diabetes, 29, 27, 10.2337/diab.29.1.27 · doi:10.2337/diab.29.1.27
  23. Bai, 1995, Insulin-degrading enzyme in a human colon adenocarcinoma cell line (Caco-2)., Pharm Res, 12, 513, 10.1023/A:1016241610649 · doi:10.1023/a:1016241610649
  24. Huber, 1980, The time course of insulin degradation in the perifused isolated fat cell., J Clin Invest, 65, 461, 10.1172/JCI109689 · doi:10.1172/jci109689
  25. Hamel, 1987, High performance liquid chromatographic analysis of insulin degradation products from isolated hepatocytes: effects of inhibitors suggest intracellular and extracellular pathways., Diabetes, 36, 702, 10.2337/diab.36.6.702 · doi:10.2337/diab.36.6.702
  26. Smith, 1990, Differences in adenosine triphosphate dependency of receptor-mediated endocytosis ofα 2-macroglobulin and insulin correlate with separate routes of ligand-receptor complex internalization., Endocrinology, 126, 1551, 10.1210/endo-126-3-1551 · doi:10.1210/endo-126-3-1551
  27. Thompson, 1989, Intranuclear localization of insulin in rat hepatoma cells: insulin/matrix association., Eur J Cell Biol, 50, 442
  28. Smith, 1990, Partial characterization of mechanism of insulin accumulation in H35 hepatoma cell nuclei., Diabetes, 39, 683, 10.2337/diab.39.6.683 · doi:10.2337/diab.39.6.683
  29. Goldfine, 1981, Electron microscope autoradiographic analysis of 125I iodoinsulin entry into adult rat hepatocytes in vivo: evidence for multiple sites of hormone localization., Endocrinology, 108, 1821, 10.1210/endo-108-5-1821 · doi:10.1210/endo-108-5-1821
  30. Smith, 1989, Biology of disease, Receptor-mediated endocytosis and intracellular processing of insulin: ultrastructural and biochemical evidence for cell-specific heterogeneity and distinction from nonhormonal ligands. In: Rubin E, Damjanov I (eds) Pathology Reviews. Humana Press Inc., Clifton, NJ, pp, 37
  31. Levy, 1987, The effect of insulin concentration on retroendocytosis in isolated rat adipocytes., Endocrinology, 120, 450, 10.1210/endo-120-2-450 · doi:10.1210/endo-120-2-450
  32. Pell, 1986, Localization of insulin degradation products to an intracellular site in isolated rat hepatocytes., Biochem Biophys Res Commun, 137, 1034, 10.1016/0006-291X(86)90329-3 · doi:10.1016/0006-291x(86)90329-3
  33. Clot, 1990, Characterization of insulin degradation products generated in liver endosomes: in vivo and in vitro studies., Mol Cell Endocrinol, 72, 175, 10.1016/0303-7207(90)90142-U · doi:10.1016/0303-7207(90)90142-u
  34. Berhanu, 1988, Internalized insulin-receptor complexes are unidirectionally translocated to chloroquine-sensitive degradative sites., J Biol Chem, 263, 5961, 10.1016/S0021-9258(18)60660-X · doi:10.1016/s0021-9258(18)60660-x
  35. Calzi, 1997, Differential effect of pp120 on insulin endocytosis by two variant insulin receptor isoforms, Am J Physiol, 273, E801
  36. Hamel, 1988, Isolation of insulin degradation products from endosomes derived from intact rat liver., J Biol Chem, 263, 6703, 10.1016/S0021-9258(18)68699-5 · doi:10.1016/s0021-9258(18)68699-5
  37. Duckworth, 1990, Cellular and endosomal degradation, In: Nishizuka Y, Endok M, Tanaka C (eds) The Biology and Medicine of Signal Transduction. Raven Press, New York, pp, 521
  38. Williams, 1990, [125I]-insulin metabolism by the rat liver in vivo: evidence that a neutral thiol-protease mediates rapid intracellular insulin degradation., Metabolism, 39, 231, 10.1016/0026-0495(90)90041-A · doi:10.1016/0026-0495(90)90041-a
  39. Seabright, 1996, The characterization of endosomal insulin degradation intermediates and their sequence of production., Biochem J, 320, 947, 10.1042/bj3200947 · doi:10.1042/bj3200947
  40. Akiyama, 1990, Natural regulatory mechanisms of insulin degradation by insulin degrading enzyme., Biochem Biophys Res Commun, 170, 1325, 10.1016/0006-291X(90)90539-Y · DOI
  41. Davies, 1986, Identification of some cleavage sites of insulin by insulin proteinase., Biochem J, 240, 609, 10.1042/bj2400609 · doi:10.1042/bj2400609
  42. Davies, 1988, Identification of radioactive insulin fragments liberated during the degradation of semisynthetic [3H]GlyA1 insulin and [3H]PheB1 insulin., Biochem J, 249, 209, 10.1042/bj2490209 · doi:10.1042/bj2490209
  43. Duckworth, 1988, High performance liquid chromatographic analysis of insulin degradation products from a cultured kidney cell line., Endocrinology, 123, 2701, 10.1210/endo-123-6-2701 · doi:10.1210/endo-123-6-2701
  44. Duckworth, 1987, Identification of A chain cleavage sites in intact insulin produced by insulin protease and isolated hepatocytes., Biochem Biophys Res Commun, 147, 615, 10.1016/0006-291X(87)90975-2 · doi:10.1016/0006-291x(87)90975-2
  45. Duckworth, 1989, High performance liquid chromatographic analysis of insulin degradation products from perfused rat kidney, Am J Physiol, 256, E208
  46. Hamel, 1986, High performance liquid chromatographic analysis of insulin degradation by rat skeletal muscle insulin protease., Endocrinology, 118, 328, 10.1210/endo-118-1-328 · doi:10.1210/endo-118-1-328
  47. Savoy, 1988, Identification by fast atom bombardment mass spectrometry of insulin fragments produced by insulin proteinase., Biochem J, 249, 215, 10.1042/bj2490215 · doi:10.1042/bj2490215
  48. Ryan, 1988, Insulin degradation: assays and enzymes. In: Kahn C, Harrison L (eds) The Insulin Receptor. Alan R. Liss, Inc.,, New York, vol, 1, 29
  49. Frank, 1983, Receptor binding properties of monoiodotyrosyl insulin isomers purified by high performance liquid chromatography., Diabetes, 32, 705, 10.2337/diab.32.8.705 · doi:10.2337/diab.32.8.705
  50. Ryan, 1984, The degradation of monoiodotyrosyl insulin isomers by insulin protease., Endocrinology, 115, 591, 10.1210/endo-115-2-591 · doi:10.1210/endo-115-2-591
  51. Mirsky, 1949, The inactivation of insulin by tissue extracts. I. The distribution and properties of insulin inactivating extracts (insulinase)., Arch Biochem, 20, 1
  52. Ryan, 1985, The calcium dependence of insulin degradation by rat skeletal muscle., Endocrinology, 117, 1693, 10.1210/endo-117-4-1693 · doi:10.1210/endo-117-4-1693
  53. Duckworth, 1994, Editorial: Increasing understanding of calmodulin-insulin interactions., J Lab Clin Med, 124, 311
  54. Duckworth, 1990, Human red blood cell insulin-degrading enzyme and rat skeletal muscle insulin protease share antigenic sites and generate identical products from insulin., J Biol Chem, 265, 2984, 10.1016/S0021-9258(19)39898-9 · doi:10.1016/s0021-9258(19)39898-9
  55. Gehm, 1993, Mutations in a zinc-binding domain of human insulin-degrading enzyme eliminate catalytic activity but not insulin binding., J Biol Chem, 268, 7943, 10.1016/S0021-9258(18)53049-0 · doi:10.1016/s0021-9258(18)53049-0
  56. Ryan, 1983, Partial characterization of an endogenous inhibitor of a calcium-dependent form of insulin protease., Biochem Biophys Res Commun, 116, 195, 10.1016/0006-291X(83)90400-X · doi:10.1016/0006-291x(83)90400-x
  57. Dykstra, 1985, Physical characterization of the cloned protease III gene from Escherichia coli K-12., J Bacteriol, 163, 1055, 10.1128/JB.163.3.1055-1059.1985 · doi:10.1128/jb.163.3.1055-1059.1985
  58. Cheng, 1979, Purification and characterization of protease III from Escherichia coli., J Biol Chem, 254, 4698, 10.1016/S0021-9258(17)30068-6 · doi:10.1016/s0021-9258(17)30068-6
  59. Ding, 1992, Comparison of the enzymatic and biochemical properties of human insulin-degrading enzyme and Escherichia coli protease III., J Biol Chem, 267, 2414, 10.1016/S0021-9258(18)45895-4 · doi:10.1016/s0021-9258(18)45895-4
  60. Kole, 1991, Purification and properties of a membrane-bound insulin binding protein, a putative receptor, from Neurospora crassa., Biochemistry, 30, 682, 10.1021/bi00217a014 · doi:10.1021/bi00217a014
  61. Kole, 1992, Characterization and partial purification of an insulinase from Neurospora crassa., Arch Biochem Biophys, 297, 199, 10.1016/0003-9861(92)90662-G · doi:10.1016/0003-9861(92)90662-g
  62. Fricke, 1995, A periplasmic insulin-cleaving proteinase (ICP) from Acinetobacter calcoaceticus sharing properties with protease III from Escherichia coli and IDE from eucaryotes., J Basic Microbiol, 35, 21, 10.1002/jobm.3620350107 · doi:10.1002/jobm.3620350107
  63. McKenzie, 1984, Partial purification and characterization of insulin protease and its intracellular inhibitor from rat liver., Arch Biochem Biophys, 229, 604, 10.1016/0003-9861(84)90193-0 · doi:10.1016/0003-9861(84)90193-0
  64. Duckworth, 1978, Insulin and glucagon binding and degradation by the kidney cell membrane., Endocrinology, 102, 1766, 10.1210/endo-102-6-1766 · doi:10.1210/endo-102-6-1766
  65. Duckworth, 1979, Insulin degradation by liver cell membranes., Endocrinology, 104, 1758, 10.1210/endo-104-6-1758 · doi:10.1210/endo-104-6-1758
  66. Yokono, 1979, Insulin-degrading activity of plasma membranes from rat skeletal muscle: its isolation, characterization, and biologic significance., Diabetes, 28, 810, 10.2337/diab.28.9.810 · doi:10.2337/diab.28.9.810
  67. Rabkin, 1992, Insulin degrading enzyme (IDE) in renal proximal tubules., Diabetes, 41, 15
  68. Hamel, 1997, Identification of the cleavage sites of transforming growth factor-alpha by insulin degrading enzymes., Biochim Biophys Acta, 1338, 207, 10.1016/S0167-4838(96)00202-6 · doi:10.1016/s0167-4838(96)00202-6
  69. Thompson, 1985, Identification of a novel receptor in Drosophila for both epidermal growth factor and insulin., Proc Natl Acad Sci USA, 82, 8443, 10.1073/pnas.82.24.8443 · doi:10.1073/pnas.82.24.8443
  70. Hamel, 1997, Intraendosomal degradation of transforming growth factor alpha., Mol Cell Endocrinol, 126, 185, 10.1016/S0303-7207(96)03981-0 · doi:10.1016/s0303-7207(96)03981-0
  71. Schade, 1985, The etiology of incapacitating brittle diabetes., Diabetes Care, 8, 18, 10.2337/diacare.8.1.12 · DOI
  72. Schade, 1985, A clinical algorithm to determine the etiology of brittle diabetes., Diabetes Care, 8, 5, 10.2337/diacare.8.1.5 · doi:10.2337/diacare.8.1.5
  73. Lau, 1990, Proteolytic degradation of human recombinant proinsulin/insulin by sera from acute pancreatitis patients and complete inhibition by Eglin-C., Pancreas, 5, 17, 10.1097/00006676-199001000-00003 · doi:10.1097/00006676-199001000-00003
  74. Stoppelli, 1988, Developmental regulation of an insulin degrading enzyme from Drosophila melanogaster., Proc Natl Acad Sci USA, 85, 3469, 10.1073/pnas.85.10.3469 · doi:10.1073/pnas.85.10.3469
  75. Kayalar, 1990, Differentiation of BC3H1 and primary skeletal muscle cells and the activity of their endogenous insulin-degrading enzyme are inhibited by the same metalloendoprotease inhibitors., J Cell Biochem, 44, 137, 10.1002/jcb.240440303 · doi:10.1002/jcb.240440303
  76. Naquet, 1987, Processing and presentation of insulin. I. Analysis of immunogenic peptides and processing requirements for insulin. A loop-specific T cells., J Immunol, 139, 3955, 10.4049/jimmunol.139.12.3955 · doi:10.4049/jimmunol.139.12.3955
  77. Semple, 1989, Processing and presentation of insulin. II. Evidence for intracellular, plasma membrane-associated and extracellular degradation of human insulin by antigen presenting B cells., J Immunol, 142, 4184, 10.4049/jimmunol.142.12.4184 · doi:10.4049/jimmunol.142.12.4184
  78. Delovitch, 1988, Pathways of processing of insulin by antigen-presenting cells., Immunol Rev, 106, 195, 10.1111/j.1600-065X.1988.tb00780.x · doi:10.1111/j.1600-065x.1988.tb00780.x
  79. Pierotti, 1994, N-Arginine dibasic convertase, a metalloendopeptidase as a prototype of a class of processing enzymes., Proc Natl Acad Sci USA, 91, 6078, 10.1073/pnas.91.13.6078 · doi:10.1073/pnas.91.13.6078
  80. Blache, 1992, Purification and partial characterization of the liver membrane endopeptidase which transforms glucagon into glucagon (19–29)., Biomed Res, 13, 51
  81. Varandani, 1972, Sequential degradation of insulin by rat liver homogenates., Proc Natl Acad Sci USA, 69, 1681, 10.1073/pnas.69.7.1681 · doi:10.1073/pnas.69.7.1681
  82. Varandani, 1980, Role of the biodegradation process in the action of insulin, A proposal for a model consisting of sulfhydryl-disulfide interchange reacter and proteolysis. In: Brandenburg D, Wollmer A (eds) Insulin, Chemistry, Structure and Function of Insulin and Related Hormones. Walter de Grayter, Berlin, pp, 475
  83. Roth, 1981, Role of disulfide interchange enzyme in immunoglobulin synthesis., Biochemistry, 20, 6594, 10.1021/bi00526a012 · doi:10.1021/bi00526a012
  84. Duckworth, 1990, Insulin degrading enzyme. In: Cuatrecasas P, Jacobs S (eds) The Handbook of Experimental Pharmacology., Springer-Verlag Press, Berlin, vol, 92, 143
  85. Pease, 1985, Degradation of endocytosed insulin in rat liver is mediated by low density vesicles., Biochem J, 228, 137, 10.1042/bj2280137 · doi:10.1042/bj2280137
  86. Bergeron, 1986, Differential and analytical subfractionation of rat liver components internalizing insulin and prolactin., Biochemistry, 25, 1756, 10.1021/bi00355a046 · doi:10.1021/bi00355a046
  87. Ward, 1985, Effects of lysosomal inhibitors on 125I insulin and 125I asioalofetuin degradation by the isolated, perfused rat liver and isolated rat hepatocytes., Diabetes, 34, 446, 10.2337/diab.34.5.446 · doi:10.2337/diab.34.5.446
  88. Ali, 1989, Glucocorticoid regulation of chloroquine nonsensitive insulin degradation in cultured fetal rat heaptocytes., J Biol Chem, 264, 20992, 10.1016/S0021-9258(19)30034-1 · doi:10.1016/s0021-9258(19)30034-1
  89. Bennett, 1996, Insulin inhibition of fatty acid β-oxidation in isolated peroxisomes., Diabetes, 45, 310
  90. Tsao, 1990, Modulation of kidney cell protein degradation by insulin., J Lab Clin Med, 116, 369
  91. Hofmann, 1983, Insulin-ricin B hybrid molecules mediate an insulin-associated effect on cells which do not bind insulin., J Biol Chem, 258, 11774, 10.1016/S0021-9258(17)44297-9 · doi:10.1016/s0021-9258(17)44297-9
  92. Miller, 1989, Stimulation of protein synthesis in stage IV Xenopus oocytes by microinjected insulin., J Biol Chem, 264, 10438, 10.1016/S0021-9258(18)81640-4 · doi:10.1016/s0021-9258(18)81640-4
  93. Miller, 1988, Stimulation of RNA and protein synthesis by intracellular insulin., Science, 240, 506, 10.1126/science.2451860 · doi:10.1126/science.2451860
  94. Miller, 1991, Stimulation of protein synthesis by internalized insulin., J Cell Physiol, 147, 487, 10.1002/jcp.1041470315 · doi:10.1002/jcp.1041470315
  95. Draznin, 1982, Inhibition of intracellular proteolysis by insulin in isolated rat hepatocytes: possible role of internalized hormone., J Biol Chem, 257, 11988, 10.1016/S0021-9258(18)33665-2 · doi:10.1016/s0021-9258(18)33665-2
  96. Peavy, 1984, Selective effects of inhibitors of hormone processing on insulin action in isolated hepatocytes., Endocrinology, 114, 753, 10.1210/endo-114-3-753 · doi:10.1210/endo-114-3-753
  97. Bennett, 1997, Characterization of the insulin inhibition of the peptidolytic activities of the insulin-degrading enzyme-proteasome complex., Diabetes, 46, 197, 10.2337/diab.46.2.197 · doi:10.2337/diab.46.2.197

Cited by

See all 871

Metadata

Authors
Duckworth, W. C., Bennett, R. G., & Hamel, F. G.
Venue
Endocrine Reviews
Published
1998-10-01
Volume
19
Issue
5
Pages
608-624
ISSN
  • 0163-769X (ISSN-L)
  • 1945-7189
OpenAlex
W2138041386
Cited by
871
References
141
FWCI
1.91
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.